Achievements
- Founded and currently serves as CEO and acting CSO of Juniper Genomics, advancing innovation in genomics
- Led Sequence Bio as Chief Business Officer, raising millions and forming partnerships with Biogen, Helix, and Sema4
- Held key roles at Cyclica, Bloom Burton & Co., Antibe Therapeutics, and Oncolytics Biotech, spanning strategy, ops, and legal leadership
- Established the Ontario Bioscience Innovation Organization and co-created mentorship programs for life sciences communities
- Legal career included partner at Norton Rose Fulbright and roles at Kirkland & Ellis, Shearman & Sterling, and Ogilvy Renault
- Academic credentials include a B.Sc. in Human Biology, Ph.D. in Molecular Genetics & Cell Biology, and a J.D. with honors from the University of Chicago
Check out Jeremy Grushcow
Yo, you gotta hear about Jeremy Grushcow. This guy’s the real deal in biotech and genomics, no cap. Like, he’s been around the block for over 20 years, and he’s crushed it in both the business and legal worlds. It’s wild how he’s combined science, law, and startups all in one process.
So, Jeremy’s from Toronto, and he’s got a legit background, B.Sc. in Human Biology from U of T, then he went all in with a Ph.D. in Molecular Genetics & Cell Biology. Not done there, he also snagged a J.D. with honors from the University of Chicago, even winning the John M. Olin Prize in Law and Economics. Dude’s smart as hell, but what’s crazy is how he used that smarts to jump into the legal game first, working at big law firms like Kirkland & Ellis, Shearman & Sterling, Ogilvy Renault, and ending up a partner at Norton Rose in Toronto.
But here’s the thing, Jeremy didn’t just stay in law. His real passion? biotech and genomics. After his legal run, he switched gears into the startup world, and that’s where he started making serious waves. He’s held key roles like Chief Business Officer at Sequence Bio, a Y Combinator startup (S19 batch), focused on using population genomics to find new drugs. That’s some advanced stuff, and he was out there raising millions, partnering with giants like Biogen, Helix, and Sema4. Basically, he’s been a legit force in connecting biotech innovation with big pharma.
Got a startup idea and seeking investment? No Cap is the first AI investor capable of investing in startups by herself.
Talk to herBefore that, Jeremy worked at Cyclica as an Operating Partner, helping steer the ship in AI-driven drug discovery. He’s also done stints at Bloom Burton & Co. as a consultant, and was EVP at Antibe Therapeutics, plus General Counsel at Oncolytics Biotech. The dude’s been across the board, strategy, ops, fundraising, legal, you name it.
What really stands out? Jeremy isn’t just about building companies. He’s all in on creating the entire system. He founded the Ontario Bioscience Innovation Organization and helped launch mentoring programs for life sciences folks. He’s focused on lifting the community as a whole, not just chasing quick wins.
Now, he’s the CEO and acting CSO at Juniper Genomics, a startup that’s jumping into the genomics space with fresh ideas. And honestly, you can see his whole process reflected in that: a mix of deep science, legal hustle, and startup grit. He’s the type of guy who sees a problem, dives in headfirst, and then uses all his tools, law, science, business, to solve it.
Bottom line? Jeremy’s story is about the relentless pursuit of innovation at the intersection of biotech and law. He’s the guy who’s not afraid to jump into the deep end, crush it, and then help everyone around him level up. No bullshit. That’s why he’s a big deal, a true builder, connector, and innovator in the biotech world.

Select your comment type:
If something is wrong about Jeremy Grushcow, there's inaccurate information or there are updates, please let us know, we'll update it for you and everyone ;)